Single Cell Western Blot

Competitive Combined Synopsis/Solicitation
HHS-NIH-NIDA-(AG)-CSS-18-376
INTRODUCTION
This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.
The solicitation number is HHS-NIH-NIDA-(AG)-CSS-18-376 and the solicitation is issued as a request for quotation (RFQ).

ACQUISITION AUTHORITY
This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures; FAR Subpart 13.5-Test Program for Certain Commercial Items; and FAR Part 12-Acquisition of Commercial Items, and is not expected to exceed the simplified acquisition threshold.
The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2005-100, dated August, 2018.
NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE
The intended procurement is classified under NAICS code 334516 Analytical Laboratory Instrument Manufacturing and the small business size standard 1000 employees.
DESCRIPTION OF REQUIREMENT
Background
The National Institutes of Health (NIH) is the nation's leading medical research agency and the primary Federal agency whose mission is to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce illness and disability, conducting, supporting and making medical discoveries that improve people's health and save lives.

The National Institutes on Aging (NIA) mission is to support and conduct genetic, biological, clinical, behavioral, social, and economic research on aging. Foster the development of research and clinician scientists in aging. Provide research resources. Disseminate information about aging and advances in research to the public, health care professionals, and the scientific community, among a variety of audiences.

The Single-Cell Western system is a platform that performs western-based protein expression measurements on single-cells to characterize protein expression heterogeneity in complex biological samples. The system completes size-based separation and micro-scale immunoassays on ~1,000 single-cells in parallel to make high fidelity protein expression measurements in each single-cell analyzed.

Purpose and Objectives:
The purpose of this requirement is to purchase a Single Cell Western System.
1. Cat. No. P300, Milo System and Two color Scanner Package Milo and Scanner Combined Offer: Instrument package includes 1 Milo System & Starter Package and 1 Two-color microarray scanner with computer. Qty. 1
2. Cat. No. A800, On Site Milo System Training On Site Milo System training. Includes 1 day
FAS time and travel costs. Qty. 1

3. Cat No. 035-106, Milo Training Kit includes a Standard scWest Kit (8 chips), frozen Jurkat cell control sample, rabbit beta tubulin primary antibody and donkey anti-rabbit IgG Northern Lights 557 secondary antibody. Qty. 1

Period of Performance - 10 days after receipt of order

Place of Performance
251 Bayview Blvd, Baltimore MD 21224
Attachment 1
FAR PART 52.212-5

Contract Type
The Government intends to issue a firm fixed price commercial items purchase order for this requirement. Invoicing shall be on a NET30 basis and payment shall be made via Electronic Funds Transfer (EFT).
There are no additional contract requirement(s) or terms and conditions applicable to this acquisition.
The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement.
APPLICABLE CLAUSES AND PROVISIONS
The following FAR clauses and provisions shall apply to this solicitation:
1. All Offerors MUST be actively registered in the System for Award Management (SAM) www.sam.gov.
2. The provision at FAR clause 52.212-1, Instructions to Offerors - Commercial Items (January 2017), applies to this acquisition.
3. FAR clause 52.212-2, Evaluation - Commercial Items (October 2014) applies to this acquisition.
4. A completed copy of the provision at FAR clause 52.212-3, Offeror Representations and Certifications - Commercial Items (January 2017), is required with any offer submitted. This requirement may be met by completion of the provision in the System for Award Management.
5. FAR clauses 52.212-4, Contract Terms and Conditions - Commercial Items (January 2017) and 52.212-5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders - Commercial Items (May 2015) apply to this acquisition. Please see attached clause with fill-ins completed.
6. The provision at FAR clause 52.211-6, Brand name or equal applies to this requisition.

RESPONSE FORMAT
Responses to this solicitation must include sufficient information to establish the interested parties' bona-fide capabilities of providing the product or service. The price quote shall include: unit price, list price, shipping and handling costs, delivery days after contract award, delivery terms, prompt payment discount terms, F.O.B. Point (Destination or Origin), product or catalog number(s); product description; and any other information or factors that may be considered in the award decision. Such factors may include: past performance; special features required for effective program performance; trade-in considerations; probable life of the item selected as compared with that of a comparable item; warranty considerations; maintenance availability; and environmental and energy efficiency considerations. Responses to this solicitation must include clear and convincing evidence of the offeror's capability of fulfilling the requirement as it relates to the technical evaluation criteria and a price proposal.
Respondents that believe that they are manufacturers or authorized resellers of the BRAND-NAME product specified in this announcement must provide, as part of their response: (a) product, catalog, model, and/or part number(s); (b) product description; (c) all relevant information and documentation that the item(s) offered meets the salient physical, functional, or performance characteristics as specified in the purchase description; quantity; estimated price or cost; shipping, handling, and/or installation charges; and delivery date after receipt of order.

Offerors must include a completed copy of the provision at 52.212-3, Offeror Representations and Certifications Commercial Items, with their offer, or provide a copy of the valid certifications registrations and Representation and Certifications from the System of Award Management (SAM) applications at www.SAM.gov, which may be indicated on the Offeror's cover sheet.

EVALUATION CRITERIA
Responses received to this RFQ will be evaluated on the basis of Lowest Price Technically Acceptable (LPTA). Offeror's submitting a response must provide a completed Price Quote to be evaluated and considered for award. Price quotes must indicate fixed unit pricing and total cost, including shipping cost and estimated time of delivery after receipt of order and any warranties. Responses to this solicitation must include clear and convincing evidence of the Offeror's capability of fulfilling the requirement as it relates to the essential government requirements stated in this solicitation. Under the lowest-price technically acceptable (LPTA) process, Offerors' will be determined to be "technically acceptable" or "technically unacceptable".

CLOSING INFORMATION
In addition the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All Offerors must have an active registration in the System for Award Management (SAM) www.sam.gov."
All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency. All responses must be received by September 14, 2018 at 12:00 pm, Eastern Standard Time (EST) and must reference solicitation number HHS-NIH-NIDA-(AG)-CSS-18-376. Responses may be submitted electronically to amcgee@mail.nih.gov or by U.S. mail to the National Institute of Drug Abuse (NIDA), Station Support / Simplified Acquisition Branch (SS/SA), 31 Center Drive, Building 31, Room 1B59, Bethesda, Maryland 20892-2080, Attention: Andrea McGee. Fax responses will be accepted at (301) 480-1358. For information regarding this solicitation, contact Andrea McGee by email at amcgee@mail.nih.gov or by phone at (301) 480-2449.

.